Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

Share Price Information for Biome Tech (BIOM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 67.50
Bid: 60.00
Ask: 75.00
Change: 6.00 (8.57%)
Spread: 15.00 (25.00%)
Open: 70.00
High: 76.00
Low: 67.50
Prev. Close: 70.00
BIOM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Biome receives £282k grant

16 Nov 2022 07:00

RNS Number : 5289G
Biome Technologies PLC
16 November 2022
 

The information contained within this announcement is deemed by the Company to constitute inside information for the purposes of Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310.

 

16 November 2022

 

Biome Technologies plc

 

("Biome", "the Company" or "the Group")

 

Biome receives £282k grant to scale-up novel biopolymers

 

Biome announces that its Bioplastics division (www.biomebioplastics.com) has been awarded £282,000 in funding from Innovate UK, the UK Government's innovation agency, to support the scale-up of novel compostable biopolymers for the flexible packaging and coatings industries in collaboration with Thomas Swan (www.thomas-swan.co.uk) and the University of Nottingham. The project has a total investment of £474,000 and is expected to last 18 months.

Over the last nine years, Biome has undertaken considerable research and development work on a range of biodegradable polymers, based on bio-based inputs. This work has involved seven universities and around 30 leading scientists and engineers. All the resultant polymers are subject to patent protection or patent application. Before this new Innovate UK grant, these novel polymers have only been scaled successfully from laboratory test-tube to small kilogram quantities on pilot plant equipment.

 

The new funding for this project will scale up one of these promising polymers to quantities of hundreds of kilograms on Thomas Swan's industrial-scale assets. This selected polymer is based on furan dicarboxylic acid (FDCA), an important new bio-based chemical. Such production will allow the performance and production process of this polymer to be evaluated at a commercially relevant scale.

 

Thomas Swan is a leading independent manufacturer of performance and fine chemicals with offices in the United States and China and a global network of distributors. The company manufactures over 100 products, from kilogram to multi-tonne quantities, and offers an experienced and flexible custom manufacturing service. Thomas Swan has collaborated with Biome's development for the last few years and is well-placed to support this specific project and ultimately manufacture Biome's novel FDCA based polymers at a commercial scale.

 

The University of Nottingham has worked with Biome for the past five years. Its contribution to this project will be led by Derek Irvine, Professor of Materials Chemistry at the institution's Faculty of Engineering. His team will support the technology transfer from the laboratory to Thomas Swan and work on further enhancements to the FDCA-derived polymer.

 

This work forms part of Biome's approach to providing highly functional added-value products to the market. It is envisaged that products derived from this collaboration will be commercialised after project completion.

 

Paul Mines, Biome Technologies' Chief Executive, commented:

 

"After nine years of significant work by Biome's scientists, engineers and supporting partners, it is great to be taking a substantial step towards industrialisation in bringing these FDCA-based polymers to the market. Thomas Swan and the University of Nottingham are great partners to support us on our journey to commercialise this new generation of bio-based and compostable polymers."

 

Harry Swan, Thomas Swan's Chief Executive and Owner, added:

 

"This is an excellent project that will see the acceleration of an important new sustainable product for Biome. It also sits well with Thomas Swan's own mission to inspire and deliver sustainable chemistry. Innovate UK grants are not easy to secure which lends great credibility to the technology and its potential. I look forward to seeing this exciting project progress with our partners, Biome and the University of Nottingham."

 

-Ends-

 

 

For further information please contact: Biome Technologies plc

 

Paul Mines, Chief Executive Officer

Rob Smith, Chief Financial Officer

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

 

Allenby Capital

David Hart/Alex Brearley (Nominated Adviser)

Kelly Gardiner (Sales and Corporate Broking)

www.allenbycapital.com

Tel: +44 (0) 20 3328 5656

 

 

About Biome

Biome Technologies plc is an AIM listed, growth-orientated, commercially driven technology group. Our strategy is founded on building market-leading positions based on patented technology and serving international customers in valuable market sectors. We have chosen to do this by developing products in application areas where the value-added pricing can be justified and are not reliant on government legislation. These products are driven by customer requirements and are compatible with existing manufacturing processes. They are market rather than technology-led.

The Group comprises two divisions, Biome Bioplastics Limited ("Bioplastic") and Stanelco RF Technologies Limited ("RF Technologies").

Biome Bioplastics is a leading developer of highly-functional, bio-based and biodegradable plastics. The company's mission is to produce bioplastics that challenge the dominance of oil- based polymers.

Stanelco RF Technologies designs, builds and services advanced radio frequency (RF) systems. Dielectric and induction heating products are at the core of a product offering that ranges from portable sealing devices to large furnaces for the fibre optics markets.

www.biometechnologiesplc.com www.biomebioplastics.com and www.thinkbioplastic.com www.stanelcorftechnologies.com

 

About Thomas Swan

Thomas Swan & Co. Ltd. is an independent chemical manufacturing company. With offices and warehousing in the UK, USA and China and a global network of distributors, they service the domestic and international markets and export to over 80 countries worldwide.

Founded in 1926 in Consett, in the North East of England - still home to their manufacturing facilities - Thomas Swan today produces over 100 products, in kilogramme to multi-tonne quantities, and offers an experienced and flexible manufacturing service.

www.thomas-swan.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFELLFLFLZFBQ
Date   Source Headline
30th Jul 20219:47 amRNSDirector/PDMR Shareholding
29th Jul 20217:00 amRNSTrading Update
1st Jul 20219:05 amRNSSecond Price Monitoring Extn
1st Jul 20219:00 amRNSPrice Monitoring Extension
1st Jul 20217:00 amRNSTrading Update
30th Jun 20215:00 pmRNSTotal Voting Rights
7th Jun 202110:50 amRNSHolding(s) in Company
2nd Jun 20217:00 amRNSIssue of Equity and TVR
28th May 20217:00 amRNSAward under 2017 Long Term Incentive Plan
30th Apr 20215:00 pmRNSTotal Voting Rights
27th Apr 20214:25 pmRNSHolding(s) in Company
21st Apr 202110:51 amRNSHolding(s) in Company
21st Apr 202110:19 amRNSResult of Annual General Meeting
21st Apr 20217:00 amRNSTrading Update
9th Apr 20211:40 pmRNSPDMR Shareholding and transaction in own shares
1st Apr 202110:04 amRNSIssue of equity and Transaction in own shares
29th Mar 20217:00 amRNSNotice of AGM and Annual Report
25th Mar 20217:01 amRNSFinal Results 2020
25th Mar 20217:00 amRNSAppointment of New Non-Executive Director
23rd Mar 20219:05 amRNSSecond Price Monitoring Extn
23rd Mar 20219:00 amRNSPrice Monitoring Extension
23rd Mar 20217:00 amRNSContract
17th Mar 20217:00 amRNSUpdate on biodegradable tree shelter project
16th Mar 20217:00 amRNSBiome commits to UN Race to Zero climate campaign
28th Jan 20217:00 amRNSTrading Update
13th Jan 20217:00 amRNSUpdate on biodegradable tree shelter project
31st Dec 20201:30 pmRNSTotal Voting Rights
15th Dec 20207:00 amRNSBiome's RF division gains traction
11th Dec 20208:05 amRNSAdmission of Subscription Shares
6th Nov 20204:41 pmRNSSecond Price Monitoring Extn
6th Nov 20204:35 pmRNSPrice Monitoring Extension
4th Nov 20207:00 amRNSBiome starts biodegradable tree shelter project
30th Oct 20205:00 pmRNSTotal Voting Rights
30th Oct 20207:00 amRNSDirector/PDMR Shareholding
29th Oct 20207:01 amRNSAppointment of Group Chief Financial Officer
29th Oct 20207:00 amRNSTrading Update
22nd Oct 202012:28 pmRNSHolding(s) in Company
19th Oct 20202:17 pmRNSHolding(s) in Company
12th Oct 20204:07 pmRNSResult of General Meeting
1st Oct 202010:55 amRNSHolding(s) in Company
24th Sep 20207:05 amRNSProposed Fundraise of £1.1 million & Notice of GM
24th Sep 20207:00 amRNSInterim Results
26th Aug 20207:00 amRNSGrant funding from Innovate UK
19th Aug 20207:00 amRNSOrder for compostable bioplastic for coffee pods
30th Jul 20207:00 amRNSTrading Update
25th Jun 20203:46 pmRNSResult of Annual General Meeting
2nd Jun 202010:35 amRNSNotice of Annual General Meeting 2020
22nd Apr 20207:00 amRNSTrading Update
20th Apr 20202:16 pmRNSAnnual Report and Accounts
16th Apr 20207:00 amRNSFinal Results 2019

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.